Feasibility and acceptability of extending delivery of SMC to children aged 5–10 years in Chad
Published:
Resources: Poster
Authors: Narcisse Tounaikok, Azoukalná Moukáneta, Mahamat Saleh Issakha Diar, Laura Donovan, Dickson Awah, Nodjiyam Dingamtela, Beakgoubá Honorá, Kevin Baker, Helen Smith, Makido Dormbaye, Sol Richardson, Charlotte Ward
Stakeholders support extending SMC to older children, but believe children 3–59 months should be reached first.
Since 2012, the World Health Organization has recommended seasonal malaria chemoprevention (SMC) for children at high risk of contracting severe malaria, in areas of sub-Saharan Africa where malaria transmission is seasonal. Routine household surveys conducted to evaluate the coverage and quality of SMC delivery in Chad found that administration of SMC medicines to children over 59 months appears to be common. This study aimed to explore the feasibility and acceptability of extending SMC to children aged 5–10 years in Chad.
This poster was presented at the 71st annual meeting of the American Society of Tropical Medicine and Hygiene.
Tagged under:
Conference
American Society of Tropical Medicine and Hygiene Annual Meeting